These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of tyrosine kinase inhibition by imatinib mesylate on mast cell tumors in dogs. Isotani M, Ishida N, Tominaga M, Tamura K, Yagihara H, Ochi S, Kato R, Kobayashi T, Fujita M, Fujino Y, Setoguchi A, Ono K, Washizu T, Bonkobara M. J Vet Intern Med; 2008; 22(4):985-8. PubMed ID: 18564222 [Abstract] [Full Text] [Related]
3. The tyrosine kinase inhibitor imatinib [STI571] induces regression of xenografted canine mast cell tumors in SCID mice. Kobie K, Kawabata M, Hioki K, Tanaka A, Matsuda H, Mori T, Maruo K. Res Vet Sci; 2007 Apr; 82(2):239-41. PubMed ID: 16919303 [Abstract] [Full Text] [Related]
8. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs. Stanclift RM, Gilson SD. J Am Vet Med Assoc; 2008 Jan 01; 232(1):53-62. PubMed ID: 18167109 [Abstract] [Full Text] [Related]
9. Lomustine for the treatment of gastrointestinal mast cell tumour in a dog. Baldi A, Colloca E, Spugnini EP. J Small Anim Pract; 2006 Aug 01; 47(8):465-7. PubMed ID: 16911116 [Abstract] [Full Text] [Related]
10. Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors. Hahn KA, Legendre AM, Shaw NG, Phillips B, Ogilvie GK, Prescott DM, Atwater SW, Carreras JK, Lana SE, Ladue T, Rusk A, Kinet JP, Dubreuil P, Moussy A, Hermine O. Am J Vet Res; 2010 Nov 01; 71(11):1354-61. PubMed ID: 21034327 [Abstract] [Full Text] [Related]
11. Treatment of canine mast cell tumors with CCNU (lomustine). Rassnick KM, Moore AS, Williams LE, London CA, Kintzer PP, Engler SJ, Cotter SM. J Vet Intern Med; 1999 Nov 01; 13(6):601-5. PubMed ID: 10587263 [Abstract] [Full Text] [Related]
14. Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors. Pryer NK, Lee LB, Zadovaskaya R, Yu X, Sukbuntherng J, Cherrington JM, London CA. Clin Cancer Res; 2003 Nov 15; 9(15):5729-34. PubMed ID: 14654558 [Abstract] [Full Text] [Related]
15. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases. Taylor F, Gear R, Hoather T, Dobson J. J Small Anim Pract; 2009 Jun 15; 50(6):284-9. PubMed ID: 19527421 [Abstract] [Full Text] [Related]
17. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004). Mullins MN, Dernell WS, Withrow SJ, Ehrhart EJ, Thamm DH, Lana SE. J Am Vet Med Assoc; 2006 Jan 01; 228(1):91-5. PubMed ID: 16426175 [Abstract] [Full Text] [Related]
18. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours. Kiupel M, Webster JD, Miller RA, Kaneene JB. J Vet Med A Physiol Pathol Clin Med; 2005 Aug 01; 52(6):280-6. PubMed ID: 16050909 [Abstract] [Full Text] [Related]
19. Evaluation of Cisplatin as an electrochemotherapy agent for the treatment of incompletely excised mast cell tumors in dogs. Spugnini EP, Vincenzi B, Citro G, Dotsinsky I, Mudrov T, Baldi A. J Vet Intern Med; 2011 Aug 01; 25(2):407-11. PubMed ID: 21382075 [Abstract] [Full Text] [Related]
20. Extracutaneous mast-cell tumor in the dog. Patnaik AK, MacEwen EG, Black AP, Luckow S. Vet Pathol; 1982 Nov 01; 19(6):608-15. PubMed ID: 6815869 [Abstract] [Full Text] [Related] Page: [Next] [New Search]